Perioperative SGLT2 Inhibitor Use is Associated With Improved Outcomes After ACDF: A Propensity-matched Analysis.

Miller M, Meade M, Delgadillo B, Sbaih O, Nanavati R, Ng M, Smith H, Gupta N, DiCiurcio W, Middleton C, Fehr S, Schroeder G, Kepler C, Woods B

Open source

DOI
10.1097/brs.0000000000005815
Published
2026 Aug 5
Container
Spine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/brs.0000000000005815,
  title = {Perioperative SGLT2 Inhibitor Use is Associated With Improved Outcomes After ACDF: A Propensity-matched Analysis.},
  author = {Miller M and Meade M and Delgadillo B and Sbaih O and Nanavati R and Ng M and Smith H and Gupta N and DiCiurcio W and Middleton C and Fehr S and Schroeder G and Kepler C and Woods B},
  year = {2026},
  journal = {Spine},
  doi = {10.1097/brs.0000000000005815},
  url = {https://doi.org/10.1097/brs.0000000000005815}
}

RIS

TY  - JOUR
TI  - Perioperative SGLT2 Inhibitor Use is Associated With Improved Outcomes After ACDF: A Propensity-matched Analysis.
AU  - Miller M
AU  - Meade M
AU  - Delgadillo B
AU  - Sbaih O
AU  - Nanavati R
AU  - Ng M
AU  - Smith H
AU  - Gupta N
AU  - DiCiurcio W
AU  - Middleton C
AU  - Fehr S
AU  - Schroeder G
AU  - Kepler C
AU  - Woods B
PY  - 2026
JO  - Spine
DO  - 10.1097/brs.0000000000005815
UR  - https://doi.org/10.1097/brs.0000000000005815
ER  - 

APA

M, M., M, M., B, D., O, S., R, N., M, N., H, S., N, G., W, D., C, M., S, F., G, S., C, K., & B, W. (2026). Perioperative SGLT2 Inhibitor Use is Associated With Improved Outcomes After ACDF: A Propensity-matched Analysis.. Spine. https://doi.org/10.1097/brs.0000000000005815

Source records